Thromboprophylaxis for Coagulopathy Related to COVID-19 in Pediatrics: A Narrative Review.
Paediatr Drugs
; 25(4): 443-452, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2318831
ABSTRACT
In addition to harming the respiratory system, COVID-19 can affect multiple organs. Children may develop a specific complication of COVID-19 called multisystem inflammatory syndrome in children (MIS-C) which could influence the vascular system of children and cause multiple coagulopathies in the body. Information on the use of thromboprophylaxis in this condition was collected via the review of various articles. In general, different factors in immune system responses can trigger the initiation of thrombotic events. Studies have shown that starting anticoagulant prophylaxis, which contributes to decreased thrombotic events, is dependent on the patient's condition and D-dimer levels. However, further studies on pediatric populations are needed to establish the role of anticoagulants in children with this condition.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Pediatría
/
Tromboembolia Venosa
/
COVID-19
Tipo de estudio:
Revisiones
Límite:
Niño
/
Humanos
Idioma:
Inglés
Revista:
Paediatr Drugs
Asunto de la revista:
Pediatría
/
Terapia por drogas
Año:
2023
Tipo del documento:
Artículo
País de afiliación:
S40272-023-00566-x
Similares
MEDLINE
...
LILACS
LIS